Publications by authors named "Thomas D Rodgers"

Claim this Profile
O
Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction.
Chenyu Lin, Clare E Anderson, Micaela R Scobie, Thomas D Rodgers, Michael J Kelley

Br J Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teleoncology in the Veterans Health Administration: Models of Care and the Veteran Experience.
Divya A Parikh, Thomas D Rodgers, Vida A Passero, Jenni C Chang, Rebecca Tisdale

Am Soc Clin Oncol Educ Book· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.
Alexandra Rezazadeh, Aniko Szabo, Arushi Khurana, David J Inwards, Matthew A Lunning, Thomas D Rodgers

Haematologica· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Veterans with blood cancers: Clinical trial navigation and the challenge of rurality.
Daphne R Friedman, Thomas D Rodgers, Courtney Kovalick, Sarvari Yellapragada, Leah Szumita

J Rural Health· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies.
Thomas D Rodgers, Carla Casulo, Frederic Boissard, Aino Launonen, Joana Parreira

Oncol Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma.
Thomas D Rodgers, AnnaLynn M Williams, Andrea Baran, Patrick M Reagan, Carla Casulo

Leuk Lymphoma· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key Clinical and Translational Research Questions to Address Unmet Needs in Mantle Cell Lymphoma.
Thomas D Rodgers, Jonathan W Friedberg

Hematol Oncol Clin North Am· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.
Anthony R Mato, Lindsey E Roeker, Ryan Jacobs, Brian T Hill, Nicole Lamanna, Thomas D Rodgers

Clin Cancer Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma.
Thomas D Rodgers, Andrea Baran, Patrick M Reagan, Carla Casulo, Clive Zent

Br J Haematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the B-cell receptor pathway: a review of current and future therapies for non-Hodgkin's lymphoma.
Thomas D Rodgers, Patrick M Reagan

Expert Opin Emerg Drugs· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pitfalls of Combining Novel Agents in Lymphoma.
Thomas D Rodgers, Paul M Barr

Curr Treat Options Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
Eric S Kim, Andrea M Baran, Esther L Mondo, Thomas D Rodgers, Gradon C Nielsen

PLoS One· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis